• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

何时的研究对于监管目的而言是充分的?一位受监管者的观点。

When are studies adequate for regulatory purposes? View of one regulated.

作者信息

Bundy M

出版信息

Environ Health Perspect. 1981 Dec;42:67-72. doi: 10.1289/ehp.814267.

DOI:10.1289/ehp.814267
PMID:7333262
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1568786/
Abstract

The question of adequacy of studies for regulatory purposes has been debated for years. Nine questions need answers to determine adequacy: (1) Does the study deal with a defined problem or a defined segment of it? (2) Do the study data justify the conclusions drawn? (3) Were appropriate statistical analyses used? Is there evidence of bias versus objectivity in the collection or analysis of data? (4) Does the study support, supplement (or complement) or refute information in the literature? Is the study truly new information? (5) Does the study conform to the Interagency Regulatory Liaison Group (IRLG) guidelines for documentation of Epidemiologic Studies? (6) Does the study stand up to peer review? (7) Have other investigators been able to confirm the findings by duplicating the study? (8) Is the study acceptable or can it be made acceptable for publication in a reputable scientific journal? (9) Is the problem of such magnitude or significance that regulation is required? Because there is no such thing as a risk-free environment or absolute safety and there is no definitive "yes" answer to each of the questions, the regulated would hope--yes, insist--that the regulators exercise judgement with great skill in promulgation of rules or regulations. The application of safety factors and the determination of acceptable levels of risk should be social decisions. A discussion of instances where the "regulated" believes that studies have not been adequate, or others habe been ignored, or misinterpreted for regulatory purposes in included.A method of settling controversial questions to eliminate the litigation route is proposed. Judgment which is so often eliminated by regulation needs to find its way back into the regulatory process. The regulated recognize the need for regulations. However, when these regulations are based on less than good scientific judgment, harm will be done to the regulatory process itself in the long run.

摘要

关于监管目的研究是否充分的问题已经争论多年。需要回答九个问题来确定其充分性:(1)该研究是否针对一个明确的问题或其明确的部分?(2)研究数据是否能证明所得出的结论?(3)是否使用了适当的统计分析?在数据收集或分析中是否存在偏向性而非客观性的证据?(4)该研究是否支持、补充(或完善)或反驳文献中的信息?该研究是否真的是新信息?(5)该研究是否符合跨部门监管联络小组(IRLG)关于流行病学研究记录的指南?(6)该研究是否经得起同行评审?(7)其他研究人员能否通过重复该研究来证实这些发现?(8)该研究是否可接受或能否使其可接受在著名科学期刊上发表?(9)该问题是否严重到需要进行监管?由于不存在无风险的环境或绝对安全,而且对每个问题都没有确定的“是”答案,受监管者会希望——是的,会坚持——监管者在制定规则或法规时能极其巧妙地运用判断力。安全系数的应用和可接受风险水平的确定应该是社会决策。文中讨论了一些情况,即“受监管者”认为研究不充分,或者其他研究被忽视,或者为了监管目的被错误解读。提出了一种解决有争议问题以避免诉讼途径的方法。常常被监管排除的判断力需要重新回到监管过程中。受监管者认识到需要法规。然而,如果这些法规基于不太好的科学判断力,从长远来看会对监管过程本身造成损害。

相似文献

1
When are studies adequate for regulatory purposes? View of one regulated.何时的研究对于监管目的而言是充分的?一位受监管者的观点。
Environ Health Perspect. 1981 Dec;42:67-72. doi: 10.1289/ehp.814267.
2
Epidemiological studies for regulatory agencies.为监管机构开展的流行病学研究。
Environ Health Perspect. 1981 Dec;42:61-5. doi: 10.1289/ehp.814261.
3
Risk management frameworks for human health and environmental risks.人类健康与环境风险的风险管理框架。
J Toxicol Environ Health B Crit Rev. 2003 Nov-Dec;6(6):569-720. doi: 10.1080/10937400390208608.
4
ICCVAM evaluation of the murine local lymph node assay. The ICCVAM review process.ICCVAM对小鼠局部淋巴结试验的评估。ICCVAM审查过程。
Regul Toxicol Pharmacol. 2001 Dec;34(3):249-57. doi: 10.1006/rtph.2001.1496.
5
Federal and state pesticide regulations and legislation.联邦和州的农药法规与立法。
Annu Rev Entomol. 1975;20:119-31. doi: 10.1146/annurev.en.20.010175.001003.
6
Part 1. Statistical Learning Methods for the Effects of Multiple Air Pollution Constituents.第1部分. 多种空气污染成分影响的统计学习方法
Res Rep Health Eff Inst. 2015 Jun(183 Pt 1-2):5-50.
7
Guidelines for documentation of epidemiologic studies. Epidemiology Work Group of the Interagency Regulatory Liaison Group.流行病学研究记录指南。跨部门监管联络小组流行病学工作组
Am J Epidemiol. 1981 Nov;114(5):609-13.
8
Government regulations--environmental and occupational health.政府法规——环境与职业健康
Am Ind Hyg Assoc J. 1981 Sep;42(9):633-6. doi: 10.1080/15298668191420413.
9
Current and historical American asbestos regulations.美国当前及过往的石棉法规。
Monaldi Arch Chest Dis. 1998 Apr;53(2):181-5.
10
Rules to be adopted for publishing a scientific paper.发表科学论文应采用的规则。
Ann Ital Chir. 2016;87:1-3.

本文引用的文献

1
The role and action of environmental agents in the pathogenesis of hung cancer. I. Air pollutants.环境因素在肺癌发病机制中的作用与影响。一、空气污染物。
Cancer. 1959 Jan-Feb;12(1):147-63. doi: 10.1002/1097-0142(195901/02)12:1<147::aid-cncr2820120121>3.0.co;2-u.
2
The unsettling UGDP controversy.
JAMA. 1980 Apr 11;243(14):1435-6.
3
Present trends in cancer epidemiology.
Proc Can Cancer Conf. 1969;8:40-75.
4
Etiology and prevention of cancer.
Prev Med. 1975 Sep;4(3):239-46. doi: 10.1016/0091-7435(75)90059-6.
5
Cancer experience among coke by-product workers.焦炭副产品工人的癌症经历。
Ann N Y Acad Sci. 1976;271:102-15. doi: 10.1111/j.1749-6632.1976.tb23099.x.
6
Atmospheric pollution and lung cancer.大气污染与肺癌
Environ Health Perspect. 1978 Feb;22:23-31. doi: 10.1289/ehp.782223.
7
Cancer and environment: Higginson speaks out.癌症与环境:希金森发声。
Science. 1979 Sep 28;205(4413):1363-4, 1366. doi: 10.1126/science.472753.
8
Toxicology of the sulfur oxides.硫氧化物的毒理学
J Occup Med. 1979 Apr;21(4):281-4.
9
Contribution of the environment to cancer incidence: an epidemiologic exercise.环境对癌症发病率的影响:一项流行病学研究。
J Natl Cancer Inst. 1977 Apr;58(4):825-32. doi: 10.1093/jnci/58.4.825.